GBR-12935

CAS No. 67469-81-2

GBR-12935( —— )

Catalog No. M15577 CAS No. 67469-81-2

GBR 12935 induced increase in the extracellular levels of dopamine to basal levels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 31 In Stock
10MG 45 In Stock
25MG 75 In Stock
50MG 97 In Stock
100MG 170 In Stock
200MG 255 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GBR-12935
  • Note
    Research use only, not for human use.
  • Brief Description
    GBR 12935 induced increase in the extracellular levels of dopamine to basal levels.
  • Description
    GBR 12935 induced increase in the extracellular levels of dopamine to basal levels.
  • In Vitro
    GBR 12909 (10-100 nM) also shows a high affinity for CYP2D6 with the Kd value of 42.2 nM, lower than the affinity for dopamine transporter. The binding effect can be reduced by Quinidine (HY-B1751) and Quinine (HY-D0143), which are the specific and potent inhibitors of CYPZD enzymatic activities.GBR 12935 dihydrochloride (10 nM; 2 min) increases the extracellular levels of dopamine to approximately 400% of basal during the application in the nucleus accumbens.GBR 12935 dihydrochloride (100 μM; 60 min) increases extracellular levels of dopamine compared with levels for artificial cerebrospinal fluid (ACSF) by local perfusion for 60 min. GBR 12935 dihydrochloride (1-9 nM) dose-dependently inhibits active uptake of [3H]dopamine in homogenates of the nucleus accumbens.Co-perfusion of 100 μM GBR 12935 dihydrochloride with either 100 μM Sulpiride (HY-B1019) or Raclopride (HY-103414) produces a significant reduction in the GBR 12935 dihydrochloride induced increase in the extracellular levels of dopamine to basal levels.
  • In Vivo
    GBR 12935 dihydrochloride (1-32 mg/kg; repeat injection; 7 d) elevates locomotion activity to a greater extent in C57BL/6J mice than DBA/2J mice, and (10 mg/kg; injection; 7 d) results few mice sensitized to cocaine-induced stereotypy with repeated injections. Animal Model:Adult male DBA/2J and C57BL/6J mice (22-30 g)Dosage:1.0, 3.2, 10, 32 mg/kg Administration:Repeat injection; for 7 days Result:Elevated locomotion activity to a greater extent in C57BL/6J mice than DBA/2J mice.No stereotypy was induced by an eighth day challenge of 10 mg/kg GBR 12935 dihydrochloride in mice pretreated with seven dally injections of either 32 mg/kg cocaine or saline.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    67469-81-2
  • Formula Weight
    487.5
  • Molecular Formula
    C28H36Cl2N2O
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    Cl.Cl.C(CN1CCN(CCOC(C2=CC=CC=C2)C2=CC=CC=C2)CC1)CC1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Norlén M, et al. Eur J Pharmacol. 1999 Feb 5;366(2-3):329-32.
molnova catalog
related products
  • GSK 789472 hydrochlo...

    GSK 789472 hydrochloride is both a dopamine D3 receptor antagonist and a D2 partial agonist.

  • Cariprazine HCl

    Cariprazine HCl is an antipsychotic drug is a D3 and D2?receptor partial agonist((Ki of 0.085 nM and 0.49 nM respectively).

  • 9-FLUORENOL

    9-FLUORENOL is a dopamine reuptake inhibitor with IC50 of 9 μM, and a major metabolite of a compound developed as a wakefulness-promoting agent.